ALB and type 2 diabetes mellitus: The Diabetics Exposed to Telmisartan and Enalapril study, which evaluated 250 patients with type 2 diabetes, reported that enalapril was not significantly superior to telmisartan for the five-year reduction of glomerular filtration rate (14.9 ml/min/1.73 m2 reduction compared with 17.9 ml/min/1.73 m2 reduction), and also showed non-significant difference in the change of serum creatinine and urinary albumin excretion [35].